Clinical trial
A Prospective Multicenter Single Arm Study to Assess the Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System for the Treatment of Subjects With Atherosclerotic Lesion(s)
NCT06779630 is registered in ClinicalTrials.gov with Teleflex as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Single Arm Study to Assess the Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System for the Treatment of Subjects With Atherosclerotic Lesion(s)
- Lead sponsor
- Teleflex
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 18, 2025
- Completion date
- September 30, 2031
- Enrollment
- 150 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.